Xenon Pharmaceuticals Inc., a company that focuses on developing treatments for neurological disorders, will be presenting at the 2023 RBC Capital Markets Global Healthcare Conference on May 16-17, 2023. The event will take place in New York, and Xenon Pharmaceuticals will be presenting a Company Fireside Chat. The presentation will be given by Ian Mortimer, the President and CEO of Xenon Pharmaceuticals, and Sherry Aulin, the CFO of the company.
Details of the Company Fireside Chat Presentation
The presentation will take place on May 16, 2023, at 3:05 pm Eastern Time and 12:05 pm Pacific Time. Xenon Pharmaceuticals will be providing a live webcast of the company presentation, which will be available on the “Investors” section of Xenon’s website. The presentation will be posted for replay following the event. The dates and times listed may be subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in developing innovative treatments to improve the lives of patients with neurological disorders. The company is advancing a pipeline of neurology therapies to address areas of high unmet medical need, with a primary focus on epilepsy.
Investor/Media Contact
For more information about Xenon Pharmaceuticals, please visit their website. Any inquiries related to investor or media relations can be directed to Jodi Regts, who works for Xenon Pharmaceuticals.
Conclusion
Xenon Pharmaceuticals is dedicated to developing innovative treatments for neurological disorders. The company’s focus on epilepsy treatment is especially important, as it is an area of high unmet medical need. The upcoming presentation at the 2023 RBC Capital Markets Global Healthcare Conference provides an opportunity for Xenon Pharmaceuticals to share their progress and successes with a larger audience. We look forward to hearing more about their work in the future.